dc.contributor.author
Mukhtar, Muhammad Dauda
dc.contributor.author
Rufa’i, Fatihu Ahmad
dc.contributor.author
Yola, Abdurrahaman Umar
dc.contributor.author
Babba, Nafisa Ibrahim
dc.contributor.author
Baecker, Daniel
dc.date.accessioned
2023-11-28T14:12:54Z
dc.date.available
2023-11-28T14:12:54Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/41639
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-41359
dc.description.abstract
The worsening of antibiotic resistance is a multifactorial process. One aspect of this is the counterfeiting of antibiotic medications. This is supposed to be particularly high in developing countries, including Nigeria. Therefore, the potency of some antibiotic drugs dispensed in community pharmacies in Gwale, Kano, Nigeria, was investigated in this case study. Three products, each from different manufacturers, with the active ingredients of ceftriaxone, gentamicin, ciprofloxacin, and metronidazole, respectively, were included in this study. By means of a disc-diffusion assay, the effect against the typed strains Staphylococcus aureus (ATCC 25923) and Escherichia coli (ATCC 25922) as well as Clostridium tetani isolated from soil was tested. Clinical isolates of S. aureus and E. coli were also used. While antibiotics, with the exception of ciprofloxacin-containing preparations against C. tetani, showed acceptable efficacy against the typed strains by comparison with the clinical science laboratory references, a predominant failure was observed with the clinical isolates. Thus, the investigated drug preparations can be considered of acceptable quality for the treatment of susceptible bacterial infections. This excludes counterfeits in the sampled preparations. However, the insufficient efficacy against clinical isolates further documents the severity of nosocomial bacteria.
en
dc.format.extent
8 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Clostridium tetani
en
dc.subject
counterfeit medications
en
dc.subject
disc-diffusion assay
en
dc.subject
drug quality
en
dc.subject
Escherichia coli
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::616 Krankheiten
dc.title
Evaluating the Potency of Selected Antibiotic Medications Dispensed in Community Pharmacies in Gwale, Kano, Nigeria
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1582
dcterms.bibliographicCitation.doi
10.3390/antibiotics12111582
dcterms.bibliographicCitation.journaltitle
Antibiotics
dcterms.bibliographicCitation.number
11
dcterms.bibliographicCitation.originalpublishername
MDPI
dcterms.bibliographicCitation.volume
12
dcterms.bibliographicCitation.url
https://doi.org/10.3390/antibiotics12111582
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie
refubium.note.author
Die Publikation wurde aus Open Access Publikationsgeldern der Freien Universität Berlin gefördert.
de
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2079-6382